Neuro Commercialization Grants - Ignite

 Banner with "Neuro Commercialization Grants: Ignite" in bold text, with the HBHL and NeuroSphere logos.

This program is now closed. 


The Healthy Brains, Healthy Lives (HBHL) initiative is a high profile, high priority multidisciplinary and cross-sectoral initiative located at McGill University made possible with support from the Canada First Research Excellence Fund (CFREF). The HBHL Strategic Research Plan outlines the vision, deliverables, and overall goals of the initiative, and the research priorities of its four research themes.

Ignite grants represent the first of two phases in the HBHL Neuro-Commercialization Grants program. The objective of the Ignite grant is to support small-scale validation/proof-of-principle efforts in the development of a neuroscience-related technology.

Funds available

Up to $50,000 for 6 months.

Funding is non-renewable.


  • Competition launch: October 20, 2022
  • Application deadline: December 19, 2022
  • Funding start date: April 1, 2023

Application process

Prerequisite: A report of Invention (ROI) must have been filed with the Innovation and Partnerships Office at McGill (I+P).

  1. Applicants will be required to meet with NeuroSphere staff prior to submitting an application to determine stage of readiness and fit for the program;
  2. Applications will be reviewed internally for eligibility and relevance;
  3. Applications will be sent to a review committee, which will review the application for program relevance and project advancement. The most promising applications will be submitted to the HBHL Innovation Committee (IC) for funding decisions;
  4. Successful applicants will be required to submit a final report to HBHL and meet with NeuroSphere at the end of the granting period to discuss their results and whether they are ready to submit an application to the Accelerate phase.


Deadline: December 19, 2022.
Back to top